NasdaqGM - Nasdaq Real Time Price USD

Sionna Therapeutics, Inc. (SION)

20.05

+0.19

+(0.96%)

As of 2:47:56 PM EST. Market Open.

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

BOSTON, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced the closing of its upsized initial public offering of 12,176,467 shares of its common stock at a public offering price of $18.00 per share

GlobeNewswire 2 days ago

SION
+0.96%
Sionna Therapeutics Prices Upsized Initial Public Offering

BOSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced the pricing of its upsized initial public offering of 10,588,233 shares of its common stock at a public offering price of $18.00 per share.

GlobeNewswire 6 days ago

SION
+0.96%
Vertex challenger Sionna prices $191M IPO

The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or be used in new, multi-drug combinations.

BioPharma Dive 6 days ago

SION
+0.96%

Performance Overview

Return	SION	S&P 500
YTD	-19.80%	+3.86%
1-Year	-19.80%	+23.33%
3-Year	-19.80%	+38.24%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Sionna Therapeutics Prices Upsized Initial Public Offering

Vertex challenger Sionna prices $191M IPO

Performance Overview